Access cutting-edge solid tumor treatment through this clinical trial at a research site in Iowa City. Study-provided care at no cost to qualified participants.
Access solid tumor specialists in Iowa City at no cost
This study follows strict safety protocols and ethical guidelines
All study-related solid tumor treatment provided free
Fibroblast activation protein (FAP) is a cell surface protein that is highly expressed on the surface of cancer-associated fibroblasts (CAFs) present in the tumor microenvironment of most epithelial cancers, whereas limited expression of FAP is observed in normal tissues. In some cancers of mesenchymal origin, notably sarcoma and mesothelioma, FAP expression has also been observed on the tumor cells themselves. Given the restricted expression profile, FAP is a promising target for peptide-target
Sponsor: Novartis Pharmaceuticals
Check if you qualify for this solid tumor clinical trial in Iowa City, IA
If you're searching for solid tumor treatment options in Iowa City, IA, this clinical trial may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Iowa City research site is actively enrolling participants for this clinical trial. You'll receive care from experienced solid tumor specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.